FDA-AACR Workshop Examines the Practice and Promise of Real-world Evidence in Oncology
Building on advances in technology and analytical tools, real-world data (RWD) sources have attracted increasing interest as means to...
Building on advances in technology and analytical tools, real-world data (RWD) sources have attracted increasing interest as means to...
AACR Project Genomics Evidence Neoplasia Information Exchange (GENIE) recently hit another milestone: the public release of a fourth dataset,...
Last year, the U.S. Food and Drug Administration approved 15 new anticancer therapeutics. More groundbreaking treatments are on the...
A major objective of former Vice President Joe Biden’s National Cancer Moonshot Initiative is breaking down silos and sharing...
The American Association for Cancer Research (AACR) has appeared in numerous publications lately, showcasing the breadth of our mission...
Members of the AACR Project GENIE consortium presented their first analyses of the data during the Pan-Cancer Genomic Analysis...
The American Association for Cancer Research (AACR) Project Genomics Evidence Neoplasia Information Exchange (GENIE) recently received funding from Genentech...
Whether cures for cancer are realized through personalized medicine, cancer vaccines, immunotherapy, or a combination of these or other...
Guest Post by Charles L. Sawyers, MD AACR Project GENIE Steering Committee Chairperson